1
|
White B, Ng SM, Agwu JC, Barrett TG, Birchmore N, Kershaw M, Drew J, Kavvoura F, Law J, Moudiotis C, Procter E, Paul P, Regan F, Reilly P, Sachdev P, Sakremath R, Semple C, Sharples K, Skae M, Timmis A, Williams E, Wright N, Soni A. A practical evidence-based approach to management of type 2 diabetes in children and young people (CYP): UK consensus. BMC Med 2024; 22:144. [PMID: 38561783 PMCID: PMC10986054 DOI: 10.1186/s12916-024-03349-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/18/2023] [Accepted: 03/11/2024] [Indexed: 04/04/2024] Open
Abstract
BACKGROUND Type 2 diabetes in young people is an aggressive disease with a greater risk of complications leading to increased morbidity and mortality during the most productive years of life. Prevalence in the UK and globally is rising yet experience in managing this condition is limited. There are no consensus guidelines in the UK for the assessment and management of paediatric type 2 diabetes. METHODS Multidisciplinary professionals from The Association of Children's Diabetes Clinicians (ACDC) and the National Type 2 Diabetes Working Group reviewed the evidence base and made recommendations using the Grading Of Recommendations, Assessment, Development and Evaluation (GRADE) methodology. RESULTS AND DISCUSSION Young people with type 2 diabetes should be managed within a paediatric diabetes team with close working with adult diabetes specialists, primary care and other paediatric specialties. Diagnosis of diabetes type can be challenging with many overlapping features. Diabetes antibodies may be needed to aid diagnosis. Co-morbidities and complications are frequently present at diagnosis and should be managed holistically. Lifestyle change and metformin are the mainstay of early treatment, with some needing additional basal insulin. GLP1 agonists should be used as second-line agents once early ketosis and symptoms are controlled. Glycaemic control improves microvascular but not cardiovascular risk. Reduction in excess adiposity, smoking prevention, increased physical activity and reduction of hypertension and dyslipidaemia are essential to reduce major adverse cardiovascular events. CONCLUSIONS This evidence-based guideline aims to provide a practical approach in managing this condition in the UK.
Collapse
Affiliation(s)
- Billy White
- University College London Hospitals NHS Foundation Trust, London, UK
| | - S M Ng
- Mersey And West Lancashire Teaching Hospitals NHS Trust, Ormskirk, UK
| | - J C Agwu
- Wye Valley NHS Trust, Hereford, UK
| | - T G Barrett
- Birmingham Women's And Children NHS Foundation Trust, Birmingham, UK
| | - N Birchmore
- Great Ormond Street Hospital For Children, NHS Foundation Trust, London, UK
| | - M Kershaw
- Birmingham Women's And Children NHS Foundation Trust, Birmingham, UK
| | - J Drew
- Nottingham University Hospitals NHS Foundation Trust, Nottingham, UK
| | - F Kavvoura
- Royal Berkshire NHS Foundation Trust, Reading, UK
| | - J Law
- Nottingham University Hospitals NHS Foundation Trust, Nottingham, UK
| | - C Moudiotis
- Royal Devon and Exeter NHS Foundation Trust, Exeter, UK
| | - E Procter
- Nottingham University Hospitals NHS Foundation Trust, Nottingham, UK
| | - P Paul
- Alder Hey Children's NHS Foundation Trust, Liverpool, UK
| | - F Regan
- Guy's and St Thomas's NHS Foundation Trust, London, UK
| | - P Reilly
- Torbay and South Devon NHS Foundation Trust, Torquay, UK
| | - P Sachdev
- Nottingham University Hospitals NHS Foundation Trust, Nottingham, UK
| | - R Sakremath
- Shrewsbury and Telford Hospital NHS Trust, Shrewsbury, UK
| | - C Semple
- University Hospitals Bristol and Weston NHS Foundation Trust, Bristol, UK
| | | | - M Skae
- Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK
| | - A Timmis
- Countess of Chester Hospital NHS Foundation Trust, Chester, UK
| | - E Williams
- Hampshire Hospitals NHS Foundation Trust, Winchester, UK
| | - N Wright
- Sheffield Children's Hospital NHS Foundation Trust, Sheffield, S102TH, UK
| | - A Soni
- Sheffield Children's Hospital NHS Foundation Trust, Sheffield, S102TH, UK.
| |
Collapse
|
2
|
Heelas L, Soni A, Barker K. Do baseline patient reported outcome measures predict changes in self-reported function, following a chronic pain rehabilitation programme? Br J Pain 2023; 17:532-545. [PMID: 37974636 PMCID: PMC10642500 DOI: 10.1177/20494637231190190] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/19/2023] Open
Abstract
Background Interdisciplinary pain management programmes, based on cognitive-behavioural principles, aim to improve physical and psychological functioning and enhance self-management in people living with chronic pain. Currently there is insufficient evidence about whether psychological, biological or social factors are predictive of positive outcomes following pain rehabilitation. This study aims to evaluate predictors of change in Brief Pain Inventory - pain interference score (BPI) in a clinical data set to determine whether age, sex and baseline outcome measures are predictive of improvement in pain interference following pain rehabilitation. Methods A retrospective, pragmatic observational analysis of routinely collected clinical data in two pain rehabilitation programmes, Balanced Life Programme (BLP) and Get Back Active (GBA) was conducted. Standard regression and hierarchical regression analyses were used to identify predictors of change to assess temporal changes in BPI. Responder analysis was also conducted. Results Standard regression analyses of 208 (BLP) and 310 (GBA) patients showed that higher baseline BPI and better physical performance measures predicted better improvement in BPI across both programmes. Hierarchical regression showed that age and sex accounted for 2.7% (BLP) and 0.002% (GBA) of the variance in change in BPI. After controlling for age and sex, the other measures explained an additional 23% (BLP) and 19% (GBA) of the variance, p = < .001 where BPI and physical performance measures were consistently statistically significant predictors, p < .05. Responder analysis also showed that pain interference and physical performance were significantly associated with improvement (p = < .0005). Conclusions The combination of high self-reported pain interference and better physical performance measures may be a useful indicator of who would benefit from interdisciplinary rehabilitation. Further validation of the results is required.
Collapse
Affiliation(s)
- L Heelas
- Physio Research Unit ouh and NDORMs, Oxford University Hospitals NHS Foundation Trust, Oxford, UK
| | - A Soni
- Nuffield Department of Clinical Neurosciences, Oxford University, Oxford, UK
- Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, Oxford University, Oxford, UK
| | - Karen Barker
- Physio Research Unit ouh and NDORMs, Oxford University Hospitals NHS Foundation Trust, Oxford, UK
| |
Collapse
|
3
|
Lin X, Soni A, Hessenow R, Stuschke M, Iliakis G. Robust Radiosensitization by Combined Treatment of Cancer Cells with Talazoparib and Polθ Inhibitors. Int J Radiat Oncol Biol Phys 2023; 117:e245. [PMID: 37784961 DOI: 10.1016/j.ijrobp.2023.06.1179] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/04/2023]
Abstract
PURPOSE/OBJECTIVE(S) The PARP inhibitor talazoparib is synthetically lethal with HR-defective tumors and functions as a potent radiosensitizer specifically of cancer cells. Talazoparib exerts this unique radiosensitizing property by shifting ionizing radiation (IR)-induced DNA double strand break (DSB) repair towards error-prone alternative end-joining (alt-EJ). DNA polymerase theta (Polθ, encoded by POLQ) is a key component of alt-EJ. Here, we tested the hypothesis that inhibition of alt-EJ with Polθ ablation or using specific small molecule inhibitors can further increase talazoparib-induced radiosensitization. MATERIALS/METHODS U2OS, A549, and their corresponding POLQ ablated/mutant cell lines were treated with talazoparib and/or Polθ inhibitors ART558/novobiocin prior to irradiation. siRNAs against CtIP, MRE11, EXO1; and a specific inhibitor of DNA2 were employed to suppress DNA end resection. Radiosensitization was assessed by clonogenic survival. Olaparib, rucaparib, and veliparib were also tested under similar conditions. DSB repair and end resection were measured by scoring γH2AX and RPA nuclear foci, respectively. Chromosomal abnormalities were assessed using G2-specific cytogenetics analysis. RESULTS Genetic ablation or pharmacological inhibition of Polθ robustly enhanced talazoparib mediated radiosensitization by ∼40-70%. Notably, Polθ inhibition had a much lower effect (by ∼7-17%) when combined with other clinically used PARP inhibitors, olaparib, rucaparib, and veliparib. Polθ inhibition significantly suppressed talazoparib-induced translocation formation in irradiated cells. In addition, combined treatment with Polθ inhibitor and talazoparib attenuated DSB repair, resulting in ∼60% unresolved γH2AX foci and ∼40% unresolved chromatid breaks at 5h post IR. Talazoparib promoted resection of DNA ends as demonstrated by an increase in RPA foci. The resection process requires the activities of CtIP and MRE11, but not of DNA2 or EXO1. Finally, CtIP and MRE11 knockdown impaired radiosensitization following a combined talazoparib/Polθ inhibition treatment. CONCLUSION Talazoparib increases the reliance of irradiated cancer cells on Polθ-mediated alt-EJ owing to the increased CtIP/MRE11-dependent resection it produces. Combining talazoparib with Polθ inhibitors has therefore great potential in improving radiotherapy of human tumors.
Collapse
Affiliation(s)
- X Lin
- Division of Experimental Radiation Biology, Department of Radiation Therapy, University Hospital Essen, University of Duisburg-Essen, Essen, Germany; Institute of Medical Radiation Biology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany
| | - A Soni
- Division of Experimental Radiation Biology, Department of Radiation Therapy, University Hospital Essen, University of Duisburg-Essen, Essen, Germany; Institute of Medical Radiation Biology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany
| | - R Hessenow
- West German Proton Therapy Center Essen (WPE), University of Duisburg-Essen, Essen, Germany
| | - M Stuschke
- Division of Experimental Radiation Biology, Department of Radiation Therapy, University Hospital Essen, University of Duisburg-Essen, Essen, Germany; German Cancer Consortium (DKTK), Partner Site University Hospital Essen, German Cancer Research Center (DKFZ), Essen, Germany
| | - G Iliakis
- Division of Experimental Radiation Biology, Department of Radiation Therapy, University Hospital Essen, University of Duisburg-Essen, Essen, Germany; Institute of Medical Radiation Biology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany
| |
Collapse
|
4
|
Soni A, Bhandari MP, Tripathi GK, Bundela P, Khiriya PK, Khare PS, Kashyap MK, Dey A, Vellingiri B, Sundaramurthy S, Suresh A, Pérez de la Lastra JM. Nano-biotechnology in tumour and cancerous disease: A perspective review. J Cell Mol Med 2023; 27:737-762. [PMID: 36840363 PMCID: PMC10002932 DOI: 10.1111/jcmm.17677] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/16/2022] [Revised: 11/07/2022] [Accepted: 11/18/2022] [Indexed: 02/26/2023] Open
Abstract
In recent years, drug manufacturers and researchers have begun to consider the nanobiotechnology approach to improve the drug delivery system for tumour and cancer diseases. In this article, we review current strategies to improve tumour and cancer drug delivery, which mainly focuses on sustaining biocompatibility, biodistribution, and active targeting. The conventional therapy using cornerstone drugs such as fludarabine, cisplatin etoposide, and paclitaxel has its own challenges especially not being able to discriminate between tumour versus normal cells which eventually led to toxicity and side effects in the patients. In contrast to the conventional approach, nanoparticle-based drug delivery provides target-specific delivery and controlled release of the drug, which provides a better therapeutic window for treatment options by focusing on the eradication of diseased cells via active targeting and sparing normal cells via passive targeting. Additionally, treatment of tumours associated with the brain is hampered by the impermeability of the blood-brain barriers to the drugs, which eventually led to poor survival in the patients. Nanoparticle-based therapy offers superior delivery of drugs to the target by breaching the blood-brain barriers. Herein, we provide an overview of the properties of nanoparticles that are crucial for nanotechnology applications. We address the potential future applications of nanobiotechnology targeting specific or desired areas. In particular, the use of nanomaterials, biostructures, and drug delivery methods for the targeted treatment of tumours and cancer are explored.
Collapse
Affiliation(s)
- Ambikesh Soni
- School of Nanotechnology, Rajiv Gandhi Proudyogiki Vishwavidyalaya, Bhopal, India
| | | | - Gagan Kant Tripathi
- School of Nanotechnology, Rajiv Gandhi Proudyogiki Vishwavidyalaya, Bhopal, India
| | - Priyavand Bundela
- School of Nanotechnology, Rajiv Gandhi Proudyogiki Vishwavidyalaya, Bhopal, India
| | | | - Purnima Swarup Khare
- School of Nanotechnology, Rajiv Gandhi Proudyogiki Vishwavidyalaya, Bhopal, India
| | - Manoj Kumar Kashyap
- Amity Stem Cell Institute, Amity Medical School, Amity University Haryana, Haryana, India
| | - Abhijit Dey
- Department of Life Sciences, Presidency University, West Bengal, Kolkata, India
| | - Balachandar Vellingiri
- Stem cell and Regenerative Medicine/Translational Research, Department of Zoology, School of Basic Sciences, Central University of Punjab, Maulana Azad National Institute of Technology, Bathinda, India
| | - Suresh Sundaramurthy
- Department of Chemical Engineering, Maulana Azad National Institute of Technology, Madhya Pradesh, Bhopal, India
| | - Arisutha Suresh
- Department of Energy, Maulana Azad National Institute of Technology & M/s Eco Science & Technology, Madhya Pradesh, Bhopal, India
| | - José M Pérez de la Lastra
- Biotecnología de macromoléculas, Instituto de Productos Naturales y Agrobiología, (IPNA-CSIC), San Cristóbal de la Laguna, Spain
| |
Collapse
|
5
|
Filippaios A, Tran KV, Mehawej J, Ding E, Paul T, Lessard D, Otabil EM, Noorishirazi K, Naeem S, Sadiq H, Howard-Wilson S, Soni A, Saczynski J, McManus DD. Patient activation and health-related quality-of-life in association with smartwatch alerts for atrial fibrillation detection. Eur Heart J 2022. [DOI: 10.1093/eurheartj/ehac544.2827] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Abstract
Abstract
Background
Smartwatches with various alert systems are becoming increasingly popular in the detection of atrial fibrillation (AF) post stroke, however their impact on psychological well-being remains unknown.
Purpose
Assess the association between smartwatch alerts for detected atrial fibrillation in older stroke survivors and patient activation as well as health-related quality-of-life.
Methods
Data were used from the Pulsewatch study, a multiphase, randomized controlled trial, which enrolled older adults (≥50 years of age) from the UMass Memorial Health System with history of a stroke and no contraindications to anticoagulation, who were given a smartwatch for AF detection. In Phase I, participants were randomized 3:1 (intervention:control) to receive a smartwatch/smartphone pair and an FDA-approved cardiac patch monitor or only the patch (control) to monitor for AF for 14 days. In Phase II, participants were re-randomized 1:1, with the intervention group being offered the smartwatch/smartphone pair for an extra 30 days. Participants were grouped into those receiving at least one alert of a possible abnormal rhythm versus those who did not receive any alerts from their smartwatch. At baseline, 14 days, and 44 days the Consumer Health Activation Index was used to assess patient activation and the Physical and Mental Component Summary of Short-Form Health Survey were utilized to evaluate physical and mental health-related quality-of-life, respectively. Mixed-effects repeated measures linear regression models were used to examine changes in patient activation and physical and mental health-related quality-of-life, in relation to alerts, adjusting for confounding variables including age, sex, race, history of arrhythmias, history of congestive heart failure, history of coronary artery disease, baseline depression, and baseline cognitive impairment, over the study period.
Results
94 participants (64.6±9.1 years of age, 87.2% non-Hispanic white, and 43.6% female) were included in the analysis; 16 of whom received at least one alert. Specifically, twelve participants received 1 to 3 alerts, three participants received 11 to 18, and one participant received 226. In fully adjusted models, receiving alerts was not associated with changes in patient activation or mental health-related quality-of-life (β −1.70, p-value 0.60 and β 2.85, p-value 0.09 respectively), but was associated with a significant reduction in physical health-related quality-of-life (β −4.67, p-value 0.04).
Conclusions
In a cohort of older stroke survivors who wore smartwatches for up to 44 days, reception of alerts was not significantly associated with changes in patient activation or mental health-related quality-of-life but was significantly related to a decline in physical health-related quality-of-life. Further studies are necessary to explore the use of smartwatches in AF screening and their impact on psychological health and quality-of-life.
Funding Acknowledgement
Type of funding sources: Public grant(s) – National budget only. Main funding source(s): R01HL137734 from the National Heart, Lung, and Blood Institute
Collapse
Affiliation(s)
- A Filippaios
- University of Massachusetts Chan Medical School , Worcester , United States of America
| | - K V Tran
- University of Massachusetts Chan Medical School , Worcester , United States of America
| | - J Mehawej
- University of Massachusetts Chan Medical School , Worcester , United States of America
| | - E Ding
- University of Massachusetts Chan Medical School , Worcester , United States of America
| | - T Paul
- University of Massachusetts Chan Medical School , Worcester , United States of America
| | - D Lessard
- University of Massachusetts Chan Medical School , Worcester , United States of America
| | - E M Otabil
- University of Massachusetts Chan Medical School , Worcester , United States of America
| | - K Noorishirazi
- University of Massachusetts Chan Medical School , Worcester , United States of America
| | - S Naeem
- University of Massachusetts Chan Medical School , Worcester , United States of America
| | - H Sadiq
- University of Massachusetts Chan Medical School , Worcester , United States of America
| | - S Howard-Wilson
- University of Massachusetts Chan Medical School , Worcester , United States of America
| | - A Soni
- University of Massachusetts Chan Medical School , Worcester , United States of America
| | - J Saczynski
- Northeastern University , Boston , United States of America
| | - D D McManus
- University of Massachusetts Chan Medical School , Worcester , United States of America
| |
Collapse
|
6
|
Vivekanantham A, Ashraf M, Soni A. AB1409 EVALUATING HOW EFFECTIVELY PATIENTS WITH A NEW INFLAMMATORY ARTHRITIS ARE BEING TRIAGED INTO THE APPROPRIATE CLINIC AT A TERTIARY CARE HOSPITAL IN THE UK: A RETROSPECTIVE AUDIT. Ann Rheum Dis 2022. [DOI: 10.1136/annrheumdis-2022-eular.3495] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
Abstract
BackgroundInflammatory arthritis is associated with significant morbidity and costs to the NHS, social care, and wider economy. Early diagnosis and treatment are essential to reduce the impact of the disease. Therefore, it is important that referrals for a new inflammatory arthritis are appropriately triaged to be seen in the early inflammatory arthritis (EIA) clinic so that they can be seen and started on disease modifying anti-rheumatoid drugs (DMARDs) without delay. The British Society of Rheumatology guidance for inflammatory arthritis states that patients must be seen within three weeks of referral and started on DMARDs within six weeks.ObjectivesTo evaluate how effectively people referred with a new EIA are currently being triaged.To evaluate whether we are meeting the national standards.MethodsWe performed a retrospective review of the medical notes of all new patients who were seen in the EIA clinic from 01/09/21-31/11/21. During this same time period, we will also reviewed all the patients who had been newly diagnosed and started on a DMARD in the other Rheumatology clinics (e.g., general rheumatology, vasculitis).We collected data on referral date, referral source (e.g., GP), date of clinic assessment, clinic type (e.g., EIA clinic or other Rheumatology clinic), diagnoses made, days’ wait from referral to assessment and days’ wait from referral to commencing DMARD.We then calculated the conversion rate (percentage of referrals triaged to the EIA clinic that have an EIA) and detection rate (percentage of new EIA patients that are seen in the EIA clinic (as opposed to in non-urgent clinics)). The standard for conversation rate (CR) was 50% and for detection rate (DR) was 95%.ResultsOf all the patients seen in the EIA clinic (n=73), 36 had a new diagnosis of an EIA, giving a CR of 49%. Of all the new diagnoses of EIA made during that time-period (n=53), 36 were appropriately triaged to be seen in the EIA clinic, giving a detection rate 68%. Those new referrals who had been appropriately seen in the EIA clinic had an average of 5 weeks wait from referral to assessment/ commencement of DMARD. In contrast, those new referrals who had been seen in other clinics had an average of 10 weeks from referral to assessment/ commencement of DMARD.A previous audit performed before the COVID-19 pandemic (01/11/19- 01/01/20) showed a CR of 25% (115 patients seen in EIA clinic, 29 new diagnoses) and a DR of 69% (29 new diagnoses, 20 seen in EIA clinic).ConclusionThose patients with a new EIA who are appropriately seen in the EIA clinic do not meet the national guidance for being seen within three weeks of referral but do meet the guidance for starting a DMARD withing six weeks. However, those new EIA who are seen outside the EIA clinic do not meet either of these standards, with a delay of 10 weeks to be seen/ started on a DMARD. Given that only 68% of people with a new EIA are being correctly triaged to be seen in the EIA clinics, it highlights that there is a need for an improvement in the triage process (currently being done manually by Rheumatologists). Interestingly, when comparing our findings to the audit done pre-COVID-19 pandemic, the CR has improved whilst the DR has stayed steady. The next steps include exploring using additional data collected from patients electronically to improve the CR/ DR rates, as well as artificial intelligence informed modelling.Disclosure of InterestsNone declared
Collapse
|
7
|
Mirza M, Escudero Siosi A, Lang D, Paddon K, Shine B, Soni A, Luqmani R. POS1549-HPR IMPROVING EFFICACY AND SAFETY OF BLOOD MONITORING IN RHEUMATOLOGY PATIENTS ON DISEASE MODIFYING ANTI-RHEUMATIC DRUGS (DMARDs) USING A NEW AUTOMATED ALGORITHM. Ann Rheum Dis 2022. [DOI: 10.1136/annrheumdis-2022-eular.2471] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
Abstract
BackgroundMost patients in Rheumatology require early management with DMARDs to control their disease. In our department, around two hundred patients start a DMARD therapy every month and monitoring their blood test results whilst on DMARDs play an essential role to detect toxicity and the need for further action. This process has been done manually, which has been prone to error. Over the past six months, a minimum of three patients have had abnormalities which were missed, consequently identifying the need to improve the quality of the blood monitoring.ObjectivesThe aim of the project was to develop, test and implement an automated algorithm to review multiple blood test results and highlight any changes, trends or abnormalities in patients starting DMARD therapy efficiently.MethodsWe designed a system to automatically review blood tests from patients newly started on DMARD therapy, following the recommended British Society for Rheumatology (BSR) schedule for blood monitoring. Results are processed in our local laboratory, subsequently uploaded to our unique database and analysed automatically using an algorithm against BSR guided threshold values for each blood test. According to the value, each blood result is identified as normal, mildly abnormal, missing, trending, or abnormal. A trained clinician or pharmacist will review the data and endorse the results after taking any appropriate action. Based on the results, if any actions are needed, patients are contacted either by phone or via a letter automatically generated by this software, recommending them to have a repeat test or temporarily stop the medication as required.ResultsThe system was tested on two cohorts, comprised of 100 and 227 blood tests. It was faster and more efficient than the manual alternative. Following this test, each record was compared manually, based on the data stored on a spreadsheet.This new system led to the identification of more abnormalities versus the manual inspection (29% vs 10%, Chi square P<0.001). Additionally, it took less than a minute compared to the manual method, which took three hours to complete. Follow up manual inspection confirmed that the new system had correctly identified every abnormality, based on test records.To date, we have analysed 3568 blood results using this technique. 1564 (44%) results have been normal and endorsed within seconds. 374 (10%) were mildly abnormal, 17 (0.5%) results have been abnormal requiring action and 311 (9%) were abnormal requiring no action. 265 (7%) results showed a trend within the blood results. Trending results were defined as being out of range and worsening on two consecutive occasions but not reaching the limits for stoppig a drug. 1032 (29%) results contained missing results, a consequence of the different timings of results uploaded by various laboratory sections.ConclusionWe have developed an efficient and safe blood monitoring system for Rheumatology patients starting on a DMARD, proven to be more accurate compared to previous manual alternatives and able to process up to 10,000 results at a time.Disclosure of InterestsNone declared
Collapse
|
8
|
Iliakis G, Mladenov E, Mladenova V, Soni A, Stuschke M, Scholz M. SP-0841 DSB complexity: A key to cell lethality. Radiother Oncol 2022. [DOI: 10.1016/s0167-8140(22)04036-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
9
|
Soni A, Wright N, Agwu JC, Timmis A, Drew J, Kershaw M, Moudiotis C, Regan F, Williams EC, Wan J, Ng SM. A practical approach to continuous glucose monitoring (rtCGM) and FreeStyle Libre systems (isCGM) in children and young people with Type 1 diabetes. Diabetes Res Clin Pract 2022; 184:109196. [PMID: 35033598 DOI: 10.1016/j.diabres.2022.109196] [Citation(s) in RCA: 6] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/12/2020] [Revised: 12/07/2021] [Accepted: 01/10/2022] [Indexed: 11/18/2022]
Abstract
Real-time continuous glucose monitoring (rtCGM) and FreeStyle Libre glucose monitoring systems (isCGM) are new evolving technologies used in the management of Type 1 diabetes. They offer potential to improve diabetes control and reduce hypoglycaemia. rtCGM can be linked to insulin pump providing hybrid closed loop therapy. Families of children and young people are keen to have the benefit from these technologies. These are relatively expensive so it is important that health care professionals, families of children and young people (CYP) with diabetes are adequately trained in the use of these devices. Health care professionals need to be able to make patient selection based on individual needs and preferences to achieve maximum benefit. Association of Children's Diabetes Clinicians (ACDC) developed a comprehensive guideline in 2017 to help identify which patients may be most likely to benefit and how these technologies may be practically implemented. Since then new technologies have been introduced and the use of GCM has expanded in routine clinical practice. This article, aims to provide a practical approach and help identify which patients may be most likely to benefit and how the technology may be implemented in order to maximise the clinical benefits.
Collapse
Affiliation(s)
- A Soni
- Sheffield Children's Hospital NHS Foundation Trust, Western Bank, Sheffield S10 2TH, United Kingdom.
| | - N Wright
- Sheffield Children's Hospital NHS Foundation Trust, Western Bank, Sheffield S10 2TH, United Kingdom
| | - J C Agwu
- Sandwell and west Birmingham Hospitals NHS Trust, United Kingdom
| | - A Timmis
- Countess of Chester Hospital NHS Foundation Trust, United Kingdom
| | - J Drew
- Nottingham University Hospitals NHS Trust, United Kingdom
| | - M Kershaw
- Birmingham Women's and Children's NHS Foundation Trust, United Kingdom
| | - C Moudiotis
- Royal Devon and Exeter NHS Foundation Trust, United Kingdom
| | - F Regan
- Frimley Health NHS Foundation Trust, United Kingdom
| | - E C Williams
- Hampshire Hospitals NHS Foundation Trust, United Kingdom
| | - Jessica Wan
- Sheffield Children's Hospital NHS Foundation Trust, Western Bank, Sheffield S10 2TH, United Kingdom
| | - S M Ng
- Southport and Ormskirk Hospital NHS Trust, United Kingdom
| |
Collapse
|
10
|
Passia E, Vis M, Coates LC, Soni A, Tchetverikov I, Gerards AH, Kok MR, Vos PAJM, Korswagen L, Fodili F, Goekoop-Ruiterman YPM, van der Kaap J, van Oosterhout M, Luime JJ. Sex-specific differences and how to handle them in early psoriatic arthritis. Arthritis Res Ther 2022; 24:22. [PMID: 35016726 PMCID: PMC8751248 DOI: 10.1186/s13075-021-02680-y] [Citation(s) in RCA: 14] [Impact Index Per Article: 7.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/15/2021] [Accepted: 09/12/2021] [Indexed: 02/08/2023] Open
Abstract
Objectives The prevalence of psoriatic arthritis (PsA) is the same in men and women; however, the latter experience a higher burden of disease and are affected more frequently by polyarthritis. Here, we performed an early PsA cohort analysis to assess sex-related differences in demographics, disease characteristics, and evolution over 1 year including applied treatment strategies. Methods Our study is embedded in the Dutch south-west Early Psoriatic Arthritis cohoRt. We described patient characteristics and treatment decisions. For the comparison across sexes and baseline and 1 year follow-up, appropriate tests depending on the distribution were used. Results Two hundred seventy-three men and 294 women with no significant differences in age and ethnicity were included. Women reported significantly longer duration of symptoms before diagnosis and significantly higher tender joint count, a higher disease activity, higher levels of pain, and lower functional capacity. Although minimal disease activity (MDA) rates increased over time for both sexes, MDA remained significantly more prevalent among men at 1 year (58.1% vs 35.7%, p < 0.00). Initially, treatment strategies were similar in both sexes with methotrexate being the most frequently used drug during the first year. Women received methotrexate for a shorter period [196 (93–364) vs 306 (157–365), p < 0.00] and therefore received a lower cumulative dose compared to men. Retention time was shorter for all DMARDs, and women had a delayed start on b-DMARDs. Conclusion After 1 year of standard-of-care treatment, women did not surpass their baseline disadvantages. Despite the overall improvement, they still presented higher disease activity, higher levels of pain, and lower functional capacity score than men. The nature of these findings may advocate a need for sex specific adjustment of treatment strategies and evaluation in early PsA patients. Supplementary Information The online version contains supplementary material available at 10.1186/s13075-021-02680-y.
Collapse
Affiliation(s)
- E Passia
- Department of Rheumatology, Erasmus University MC, NB 850, PO box 2040, 3315EJ, Rotterdam, The Netherlands
| | - M Vis
- Department of Rheumatology, Erasmus University MC, NB 850, PO box 2040, 3315EJ, Rotterdam, The Netherlands
| | - L C Coates
- Nuffield Department of Orthopedics, Rheumatology and Musculoskeletal Sciences, Un. of Oxford, Oxford, UK
| | - A Soni
- Nuffield Department of Orthopedics, Rheumatology and Musculoskeletal Sciences, Un. of Oxford, Oxford, UK
| | | | | | - M R Kok
- Maasstad H., Rotterdam, The Netherlands
| | | | | | - F Fodili
- Reumazorg Zuid West Nederland, Roosendaal, The Netherlands
| | | | - J van der Kaap
- Department of Rheumatology, Erasmus University MC, NB 850, PO box 2040, 3315EJ, Rotterdam, The Netherlands
| | | | - J J Luime
- Department of Rheumatology, Erasmus University MC, NB 850, PO box 2040, 3315EJ, Rotterdam, The Netherlands.
| |
Collapse
|
11
|
Khan A, Singh R, Sharma S, Singh V, Sheoran A, Soni A, Dhull V, Gill PS, Yadav A, Chaudhary D, Gupta MC, Mehta PK. Diagnosis of osteoarticular tuberculosis by immuno-PCR assay based on mycobacterial antigen 85 complex detection. Lett Appl Microbiol 2021; 74:17-26. [PMID: 34592012 DOI: 10.1111/lam.13567] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/16/2021] [Revised: 09/11/2021] [Accepted: 09/14/2021] [Indexed: 01/22/2023]
Abstract
Diagnosis of osteoarticular tuberculosis (OATB) exhibits serious challenges owing to paucibacillary nature of specimens and localization of disease at sites that are difficult to access. We recently developed indirect immuno-PCR (I-PCR) and real-time I-PCR (RT-I-PCR) assays for the detection of mycobacterial antigen 85 complex (Ag85) in OATB patients. Detection limits for the purified Ag85 protein were found to be 1 and 41 fg ml-1 by I-PCR and RT-I-PCR, respectively, which were at least 105 -fold lower than respective ELISA. While spiking synovial fluids of non-TB control subjects with the purified Ag85 protein, LODs of 100 and 120 fg ml-1 were obtained by I-PCR and RT-I-PCR, respectively, thus demonstrating the sample matrix effect. Sensitivities of 87·5 and 70·5% were observed in bodily fluids of confirmed (n = 8) and clinically suspected (n = 51) OATB cases, respectively, by I-PCR, with a specificity of 93·9% (n = 33). Markedly, the sensitivities obtained by I-PCR/RT-I-PCR were significantly higher (P < 0·05-0·01) than ELISA and GeneXpert assay (n = 30). However, no substantial difference in sensitivity was observed between the I-PCR and RT-I-PCR assays. After further improving the accuracy of I-PCR, this test may lead to development of an attractive diagnostic kit.
Collapse
Affiliation(s)
- A Khan
- Centre for Biotechnology, Maharshi Dayanand University (MDU), Rohtak, India
| | - R Singh
- Department of Orthopaedics, University of Health Sciences (UHS), Rohtak, India
| | - S Sharma
- Department of Microbiology, UHS, Rohtak, India
| | - V Singh
- Department of Biostatistics, All India Institute of Medical Sciences, New Delhi, India
| | - A Sheoran
- Department of Statistics, Ramanujan College, University of Delhi, New Delhi, India
| | - A Soni
- Centre for Biotechnology, Maharshi Dayanand University (MDU), Rohtak, India.,Department of Biotechnology, Deenbandhu Chhotu Ram University of Science and Technology Murthal, Sonepat, India
| | - V Dhull
- Department of Biotechnology Engineering, University Institute of Engineering & Technology, MDU, Rohtak, India
| | - P S Gill
- Department of Microbiology, UHS, Rohtak, India
| | - A Yadav
- Department of Microbiology, UHS, Rohtak, India
| | - D Chaudhary
- Pulmonary and Critical Care Medicine, UHS, Rohtak, India
| | - M C Gupta
- Department of Pharmacology, UHS, Rohtak, India
| | - P K Mehta
- Centre for Biotechnology, Maharshi Dayanand University (MDU), Rohtak, India
| |
Collapse
|
12
|
Soni A, Gupta RK, Raghav M, Masih GD, Bansal P. Comparison of Bone-Patellar Tendon-Bone Graft, Semitendinosus-Gracilis Graft and Semitendinosus-Gracilis with Preserved Tibial Insertion Graft in Anterior Cruciate Ligament Reconstruction in Sports Persons. Malays Orthop J 2021; 15:12-17. [PMID: 34429817 PMCID: PMC8381676 DOI: 10.5704/moj.2107.003] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/30/2020] [Accepted: 04/04/2021] [Indexed: 11/05/2022] Open
Abstract
Introduction Bone-patellar tendon-bone (BPTB) and semitendinosus-gracilis (STG) are the commonest grafts used for ACL reconstruction. However even after having been debated for years, there is no consensus about the ideal graft. Moreover, the literature is deficient about STG graft with preserved tibial insertion (STGPI) which preserves the proprioception. Our aim is to compare the outcome of BPTB, free STG and STGPI grafts after ACL reconstruction in professional sports persons. We compared the outcome in terms of mechanical stability, functional outcome, return to sports activity and degenerative changes. Material and Methods Professional sports persons aged between 16-50 years operated for ACL tear using BPTB, free STG and STGPI grafts with minimum follow-up of two years were identified from hospital records. Patients with associated knee injuries were excluded. Patients, divided in three groups according to graft used, were compared in terms of mechanical stability (arthrometric examination KT-1000 score), functional outcome (Lysholm Score), return to sports activity (Tegner score and difference in thigh circumference) and degenerative changes (KL grading). Results BPTB graft group was found to be better than free STG and STGPI graft groups in terms of KT-1000 score. There was no statistically significant difference among the groups in terms of Lysholm score, Tegner score, difference in thigh circumference and KL grading. Conclusion BPTB graft is better than free STG and STGPI grafts in terms of knee stability. When compared for patient reported outcome, return to sports activity, osteoarthritic changes and graft failure there is no significant difference among the three types of grafts.
Collapse
Affiliation(s)
- A Soni
- Department of Orthopaedics, Government Medical College and Hospital, Chandigarh, India
| | - R K Gupta
- Department of Orthopaedics, Government Medical College and Hospital, Chandigarh, India
| | - M Raghav
- Department of Orthopaedics, Government Medical College and Hospital, Chandigarh, India
| | - G D Masih
- Department of Orthopaedics, Government Medical College and Hospital, Chandigarh, India
| | - P Bansal
- Department of Orthopaedics, Government Medical College and Hospital, Chandigarh, India
| |
Collapse
|
13
|
Balwant P, Jyothi V, Pujari PR, Soni A, Padmakar C, Quamar R, Ramesh J, Gohel V, Mishra A. Integrated hydrochemical and ERT approach for seawater intrusion study in a coastal aquifer: a case study from Jafrabad Town, Gujarat State, India. Environ Monit Assess 2021; 193:558. [PMID: 34365552 DOI: 10.1007/s10661-021-09251-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 03/06/2021] [Accepted: 06/28/2021] [Indexed: 06/13/2023]
Abstract
Hydrochemical and geophysical approach has been adopted to evaluate the seawater intrusion (SWI) in coastal aquifers of Jafrabad Town, Gujarat State, India. Electrical Resistivity Tomography (no. 9) was carried out with spread length of 160-400 m which provided penetration depth of about 23 to 76 m. Very low resistivity zone (0-3 Ω-m range) has been observed in the ERT profiles conducted in the study area. Parameters, namely, TDS, Na, and Cl, have been considered to examine the signature of SWI. The results obtained from ionic ratios, Piper plot, and Chaddha's diagram also confirm the influence of saline water within aquifer. The very low resistivity signature is correlated with the high TDS values in the nearby wells. SWI has been observed up to 9 km from the coast, and it is observed at a depth of 20-22 m in the existing limestone mines near the coast.
Collapse
Affiliation(s)
- Pandurang Balwant
- CSIR-National Environmental Engineering Research Institute, Nagpur, India
| | - V Jyothi
- CSIR-National Environmental Engineering Research Institute, Nagpur, India
| | - Paras R Pujari
- CSIR-National Environmental Engineering Research Institute, Nagpur, India.
| | - A Soni
- CSIR-Central Institute of Mining and Fuel Research, Nagpur, India
| | - C Padmakar
- CSIR-National Environmental Engineering Research Institute, Nagpur, India
| | - R Quamar
- CSIR-National Environmental Engineering Research Institute, Nagpur, India
| | - J Ramesh
- CSIR-National Environmental Engineering Research Institute, Nagpur, India
| | - V Gohel
- CSIR-National Environmental Engineering Research Institute, Nagpur, India
| | - A Mishra
- CSIR-National Environmental Engineering Research Institute, Nagpur, India
| |
Collapse
|
14
|
Affiliation(s)
- DL Lakhkar
- Department of Radiodiagnosis, Bharati Vidyapeeth Medical College and; Hospital deemed university. Dhankawadi. PUNE-43, India
| | - M Yadav
- Department of Radiodiagnosis, Bharati Vidyapeeth Medical College and; Hospital deemed university. Dhankawadi. PUNE-43, India
| | - A Soni
- Department of Radiodiagnosis, Bharati Vidyapeeth Medical College and; Hospital deemed university. Dhankawadi. PUNE-43, India
| | - M Kumar
- Department of Radiodiagnosis, Bharati Vidyapeeth Medical College and; Hospital deemed university. Dhankawadi. PUNE-43, India
| |
Collapse
|
15
|
Malley T, Jackman J, Manderson S, Saldana Pena L, Evans E, Barrett J, Soni A, Luqmani R. POS0152-HPR REMOTE CLINICAL MANAGEMENT: INCORPORATING ELECTRONIC ASSESSMENT OF PATIENTS WITH RHEUMATIC DISEASES INTO STANDARD CLINICAL PATHWAYS DURING THE COVID-19 PANDEMIC: A PILOT STUDY. Ann Rheum Dis 2021. [DOI: 10.1136/annrheumdis-2021-eular.309] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
Abstract
Background:Many patients with rheumatic disease require immunosuppressive medication putting them at high risk of COVID-19 infection. Reduced staffing in rheumatology due to redeployment to COVID-19 work, limited out patient capacity and patient vulnerability have had a major impact on our ability to review our patients to assess their condition and treatment (by face-to-face, video or telephone consultations). Novel strategies are essential to safely and effectively treat patients with rheumatic disease whilst minimising their risk of exposure to COVID-19 infection.Objectives:The objective was to develop a digital solution to help deliver safe, efficient and effective care for patients with rheumatic diseases. The aim was to produce a system that allowed us to integrate data recorded directly by patients with information held in our electronic health records to provide a virtual review of care.Methods:An online questionnaire was used to collect clinical information, including validated disease activity measures, to conduct a remote assessment in 175 patients awaiting follow-up appointments. This assessment was integrated within our electronic health records (EHR). The questionnaire contained measures of disease activity (DAS28 or BASDAI); patient reported outcomes; patient preferences regarding the urgency and type of appointment; any recent problems or changes in medication. This information was imported into a database for clinician review, together with previous clinical records and results of relevant investigations, to inform clinical decisions and to decide on the safest and most appropriate timing for follow-up. Report letters were sent to the patient and their primary care providers.Results:Of the 175 patients (149 with RA and 26 with AS), 108 patients (89/149 [60%] with RA [mean age=64; female=65%] and 19/26 [73%] with AS [mean age=45; female=54%]) submitted responses over a 6-week period based on which clinical decisions were made. The mean questionnaire completion time was 19 minutes for RA responders and 16 minutes for AS responders. Non responders (67/175 [mean age=61; female=63%]) remained on our list of patients awaiting follow-up arrangements to be made. Sixty-nine responders (64%) had stable disease therefore did not require any changes to their treatment and were offered an appointment within the next 6 months, of whom 12 (11%) requested face-to-face follow-up. Of the remaining 39 – with less stable disease – requiring more rapid follow-up assessment, 22 patients (56%) required a face-to-face consultation to consider treatment change. So far 9 of these patients have had follow-up, of whom 6 necessitated treatment escalation (Methotrexate increase n=2; anti-inflammatory increase n=2; intramuscular steroid n=1; anti-TNF escalation n=1). Thirty-nine patients (36%) provided feedback on the process of completing the questionnaire, 85% of whom used a mobile phone and the remainder used a computer or tablet. The majority (70%) found it “extremely easy” or “somewhat easy” to complete; remaining responses: “neutral” 20%, “somewhat difficult” 10%, “extremely difficult” 0%.Conclusion:We have created and tested a system of remote clinical management for patients with RA and AS. Amongst the 108 responders, just 31% required a face-to-face appointment, with treatment changes made accordingly. With a backlog of 3,800 awaiting allocation to follow-up appointments, remote clinical management will allow us to safely and efficiently prioritise patients requiring urgent follow-up for treatment optimisation. We will integrate this system into our standard care pathway beyond the COVID-19 pandemic to streamline our service, deliver effective care and provide evidence to support the use of costly biologic drugs.1 We plan to investigate the barriers for non-responders.References:[1]Holroyd CR, Seth R, Bukhari M, et al. The British Society for Rheumatology biologic DMARD safety guidelines in inflammatory arthritis. Rheumatology. 2019; 58 (2): e3–e42.Disclosure of Interests:Tamir Malley: None declared, John Jackman: None declared, Sarah Manderson: None declared, Larissa Saldana Pena Grant/research support from: Pfizer’s Global Medical Grants program, Ellie Evans: None declared, Joe Barrett Grant/research support from: Pfizer’s Global Medical Grants program, Anushka Soni Grant/research support from: Pfizer’s Global Medical Grants program, Raashid Luqmani Grant/research support from: Pfizer’s Global Medical Grants program
Collapse
|
16
|
Chanda A, Chauhan A, Kaur P, Soni A, Sehgal S, Khurana A, Parkash O, Verma Y. P37.11 Assessment of Plasma D-Dimer as a Predictive Biomarker for Treatment Response in Lung Cancer Treated with Radiation Therapy. J Thorac Oncol 2021. [DOI: 10.1016/j.jtho.2021.01.758] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
17
|
Chauhan A, Chanda A, Kaur P, Soni A, Sehgal S, Khurana A, Verma Y, Parkash O. P30.06 Outcome Differences Amongst Histopathological Variants of Non Small Cell Lung Cancer Treated With Palliative Radiotherapy. J Thorac Oncol 2021. [DOI: 10.1016/j.jtho.2021.01.651] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
18
|
Gupta R, Singhal A, Malhotra A, Soni A, Masih GD, Raghav M. Predictors for Anterior Cruciate Ligament (ACL) Re-injury after Successful Primary ACL Reconstruction (ACLR). Malays Orthop J 2021; 14:50-56. [PMID: 33403062 PMCID: PMC7752004 DOI: 10.5704/moj.2011.009] [Citation(s) in RCA: 9] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/13/2023] Open
Abstract
Introduction: Few authors have addressed risk factors related to an ipsilateral graft rupture and contralateral anterior cruciate ligament (ACL) injury after return to sports (RTS) following primary ACL reconstruction. Material and Methods: Patients with ACL re-injury to either knee after successful primary ACLR were included in Group I and those with no further re-injury were included in Group II. Variables including age, gender, side, body mass index (BMI), thigh atrophy, anterior knee laxity difference between both knees measured by KT-1000 arthrometer, mean time of return to sports (RTS), graft type, type of game, mode of injury, Tegner Activity Score, hormone levels, femoral tunnel length (FTL), posterior tibial slope (PTS) and notch width index (NWI) were studied. Binary logistic regression was used to measure the relative association. Results: A total of 128 athletes were included with 64 in each group. Mean age in Group I and II were 24.90 and 26.47 years respectively. Mean follow-up of Group I and Group II were 24.5 and 20.11 months respectively. Significant correlation was present between ACL re-injury and following risk factors; PTS of >10º, KT difference of >3.0mm, thigh atrophy of >2.50cm and time to RTS <9.50 months P value <0.05). No correlation was found with age, sex, BMI, type of game, Tegner Activity Score, mode of injury, NWI, size of graft, FTL and hormone levels. Conclusion: Possible risk factors include PTS of ≥ 10º, KT difference of ≥ 3.0mm at 1 year follow-up, thigh atrophy of ≥ 2.50cm at 1 year follow-up and RTS <9.5 months after primary ACLR.
Collapse
Affiliation(s)
- R Gupta
- Department of Orthopaedics, Government Medical College Hospital Chandigarh, Chandigarh, India
| | - A Singhal
- Department of Orthopaedics, Government Medical College Hospital Chandigarh, Chandigarh, India
| | - A Malhotra
- Department of Orthopaedics, Government Medical College Hospital Chandigarh, Chandigarh, India
| | - A Soni
- Department of Orthopaedics, Government Medical College Hospital Chandigarh, Chandigarh, India
| | - G D Masih
- Department of Orthopaedics, Government Medical College Hospital Chandigarh, Chandigarh, India
| | - M Raghav
- Department of Orthopaedics, Government Medical College Hospital Chandigarh, Chandigarh, India
| |
Collapse
|
19
|
Ng SM, Lay JT, Regan F, Soni A, Wright N, Agwu JC, Williams E, Timmis A, Kershaw M, Moudiotis C, Drew J. Variations in diabetes transition care for children and young people: a national survey. Diabet Med 2020; 37:1407-1409. [PMID: 32511813 DOI: 10.1111/dme.14336] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/16/2020] [Revised: 05/21/2020] [Accepted: 05/23/2020] [Indexed: 12/01/2022]
Affiliation(s)
- S M Ng
- Paediatric Department, Southport and Ormskirk NHS Trust, Ormskirk, UK
- Department of Women's and Children's Health, University of Liverpool, Liverpool, UK
| | - J T Lay
- Paediatric Department, Southport and Ormskirk NHS Trust, Ormskirk, UK
| | - F Regan
- Wexham Park Hospital, Slough, UK
| | - A Soni
- Sheffield Children's NHS Foundation Trust, Sheffield, UK
| | - N Wright
- Sheffield Children's NHS Foundation Trust, Sheffield, UK
| | - J C Agwu
- Department of Paediatrics, Sandwell and West Birmingham NHS Trust, Birmingham, UK
- Institute of Clinical Sciences, College of Medicine and Dental Sciences, University of Birmingham, Birmingham, UK
| | - E Williams
- Hampshire Hospitals NHS Foundation Trust, Winchester, UK
| | - A Timmis
- Countess of Chester Hospital NHS Foundation Trust, Chester, UK
| | - M Kershaw
- Birmingham Children's Hospital NHS Foundation Trust, Birmingham, UK
| | - C Moudiotis
- Department of Paediatrics, Royal Devon and Exeter NHS Foundation Trust, Exeter, UK
| | - J Drew
- Department of Paediatrics, Nottingham University Hospitals NHS Trust, Nottingham, UK
| |
Collapse
|
20
|
Ramesh C, Pandey J, Tyagi P, Soni A, Senthil Kumar M, Kushvaha SS. Excitation Density Dependent Photoluminescence Studies on Homo-Epitaxial GaN Nanowall Networks Grown by Laser Assisted Molecular Beam Epitaxy. J Nanosci Nanotechnol 2020; 20:3866-3872. [PMID: 31748088 DOI: 10.1166/jnn.2020.17509] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/10/2023]
Abstract
The optical properties of laser-assisted molecular beam epitaxy grown homo-epitaxialGaN nanowall networks (NWNs) were investigated using power dependent photoluminescence (PL) spectroscopy and compared with homo-epitaxial GaN thin film. The pore size and tip width of GaN NWN sample is ˜120-180 nm and 10-15 nm, respectively. The ultraviolet-visible spectroscopy study shows that the GaN NWNs have low optical light reflection and minimum Fabry-Perot cavity effect than GaN film. The room temperature PL spectroscopy reveals that the GaN NWNs possesses enhanced band gap of 3.51 eV with blue shift of 90 meV than the GaN film (3.42 eV). The excitation density dependent PL spectroscopy measurements reveal that the GaN NWNs nanowall and near band emission (NBE) peak position and its linewidth invariant. The intensity of NBE peak for GaN film and nanowalls varies linearly whereas NBE to defect related yellow luminescence peak intensity ratio shows a non-linear variation on the excitation density. The excitation density in PL measurements plays a key role when the sample quality compared on the basis of PL data.
Collapse
Affiliation(s)
- Ch Ramesh
- CSIR-National Physical Laboratory, Dr. K. S. Krishnan Marg, New Delhi 110012, India
| | - J Pandey
- School of Basic Sciences, Indian Institute of Technology Mandi, Mandi 175005, HP, India
| | - P Tyagi
- CSIR-National Physical Laboratory, Dr. K. S. Krishnan Marg, New Delhi 110012, India
| | - A Soni
- School of Basic Sciences, Indian Institute of Technology Mandi, Mandi 175005, HP, India
| | - M Senthil Kumar
- CSIR-National Physical Laboratory, Dr. K. S. Krishnan Marg, New Delhi 110012, India
| | - S S Kushvaha
- CSIR-National Physical Laboratory, Dr. K. S. Krishnan Marg, New Delhi 110012, India
| |
Collapse
|
21
|
Passia E, Vis M, Coates LC, Soni A, Tchetverikov I, Gerards A, Korswagen LA, Kok MR, Van der Graaff W, Veris-van Dieren J, Denissen N, Fodili F, Starmans M, Goekoop-Ruiterman Y, Van Oosterhout M, Luime J. OP0057 SEX SPECIFIC DIFFERENCES IN EARLY PSORIATIC ARTHRITIS. Ann Rheum Dis 2020. [DOI: 10.1136/annrheumdis-2020-eular.3461] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
Abstract
Background:Although the prevalence of Psoriatic Arthritis (PsA) is the same in men and women, women experience a higher burden of disease (pain, disability, fatigue) (1).The persistent belief that women tend to over-report their symptoms compared to men may also contribute to under or delayed diagnosis in women. The clinical pattern of PsA also differs, with men presenting more commonly with peripheral and axial joint damage and women being affected more frequently by polyarthritis (2). Furthermore, most disease activity measures contain pain and quality of life measurement metrics that may perform differently by sex. As a result, this may affect the clinician’s perception of disease severity, influence management decisions and subsequently introduce sex bias in prescribing.Objectives:To assess sex-related differences in baseline demographics, disease characteristics and evolution over 1 year in patients with newly diagnosed PsA.Methods:Our study is embedded in the Dutch south-west Early Psoriatic Arthritis prospective cohort study. We described patient characteristics using simple descriptive analysis techniques. For the comparison across sexes and baseline and 1 year follow up, appropriate tests depending on the distribution were used.Results:273 men and 294 women with no significant differences in age and ethnicity were included. Women reported significantly longer duration of symptoms before diagnosis and significantly fewer of them were in paid employment at baseline. Oligoarthritis was the most common pattern of arthritis in both sexes. Polyarthritis and enthesitis were more prevalent in women who also presented at baseline a significantly higher tender joint count (Fig.1) than men but no difference in swollen joint count.Figure 1.Longitudinal evolution of TJC68, Pain, VAS global, BRAF for men and women in the first year of PsA.All composite indices (CPDAI, DAPSA, GRACE, MDA, Psoriatic ArthritiS Disease Activity Score) showed significantly worse results in women at baseline. Women also suffered more frequently from comorbid medical conditions, fatigue and anxiety, and reported more severe limitations in function and worse quality of life.At 12 months women, despite the improvement they made, reported significantly higher levels of pain compared to men. Although MDA rates increase over time for both sexes,(Fig.2), it remained significantly more prevalent among men (19.0% vs 11.1% at inclusion,p<0.05, and 58.1% vs 35.7%,p<0.00, at T12). DAPSA was significantly higher in women at both timepoints and a significantly higher percentage of men presented remission according to DAPSA score at 12 months.Figure 2.Longitudinal evolution of composite measures for men and women in the first year of PsA.Conclusion:After 1 year of follow-up women didn’t surpass their baseline disadvantages and despite the improvement, they still present higher disease activity, more pain and lower functional capacity than men. The nature of these findings may advocate a need for sex specific adjustment of treatment strategies and evaluation in psoriatic arthritis as sex-related difference in outcome persisted over time.References:[1]Eder L, Thavaneswaran A, Chandran V, Gladman DD. Gender difference in disease expression, radiographic damage and disability among patients with psoriatic arthritis. Annals of the rheumatic diseases. 2013;72(4):578-82.[2]Orbai AM, Perin J, Gorlier C, Coates LC, Kiltz U, Leung YY, et al. Determinants of Patient-Reported Psoriatic Arthritis Impact of Disease: An Analysis of the Association with Gender in 458 Patients from 14 Countries. Arthritis care & research. 2019.Disclosure of Interests:Evangelia Passia: None declared, Marijn Vis Grant/research support from: Novartis, Pfizer – grant/research support, Consultant of: AbbVie, Celgene Corporation, Eli Lilly, Novartis, Pfizer – consultant, Laura C Coates: None declared, Anushka Soni Grant/research support from: Oxford-UCB prize fellowship, Speakers bureau: Janssen and Abbvie, Ilja Tchetverikov: None declared, Andreas Gerards: None declared, Lindy-Anne Korswagen: None declared, Marc R Kok Grant/research support from: BMS and Novartis, Consultant of: Novartis and Galapagos, Wiebo van der Graaff: None declared, Josien Veris-van Dieren: None declared, Natasja Denissen: None declared, F. Fodili: None declared, M. Starmans: None declared, Yvonne Goekoop-Ruiterman: None declared, M. van Oosterhout: None declared, Jolanda Luime: None declared
Collapse
|
22
|
Talukder S, Mendiratta SK, Kumar RR, Agrawal RK, Soni A, Luke A, Chand S. Jamun fruit ( Syzgium cumini) skin extract based indicator for monitoring chicken patties quality during storage. J Food Sci Technol 2020; 57:537-548. [PMID: 32116363 PMCID: PMC7016058 DOI: 10.1007/s13197-019-04084-y] [Citation(s) in RCA: 17] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Revised: 08/31/2019] [Accepted: 09/04/2019] [Indexed: 11/25/2022]
Abstract
Natural plant pigment, anthocyanins have the capability to change its color with the change of its structure influenced by changing pH. This feature of anthocyanin has been harnessed to design a meat products quality indicator. In the present experiment anthocyanin rich Jamun fruit (Syzgium cumini) skin extract was used to develop quality indicator by immobilizing on filter paper strips with the purpose of application in chicken patties packets stored at refrigeration temperature (4 ± 1 °C). The indicator changed its color from violet to yellow due to changed pH in it when it was attached inside packet of chicken patties during storage, due to reaction with volatile basic compounds generated from meat. During storage for 21 days, various changes in quality attributes of chicken patties viz., pH, Total volatile basic nitrogen (TVBN), ammonia level, color value, sensory attributes and microbial evaluation were estimated. The pH decreased (P < 0.5) from 6.22 to 6.04. TVBN and ammonia and level increased significantly (P < 0.5) throughout storage. Redness, yellowness, hue and chroma value gradually changed during storage. Sensory scores also decreased significantly (P < 0.5). Microbial count also increased (P < 0.5) during this time. The experiment showed that, during storage, the color changing pattern of quality indicator was well correlated with the changes in quality attributes of chicken meat patties. Therefore, it is expected that the developed quality indicator can provide a convenient, non destructive, visual mean to monitor the meat products quality during refrigerated storage.
Collapse
Affiliation(s)
- S. Talukder
- Division of Livestock Products Technology, ICAR-Indian Veterinary Research Institute, Izatnagar, Bareilly, UP 243122 India
| | - S. K. Mendiratta
- Division of Livestock Products Technology, ICAR-Indian Veterinary Research Institute, Izatnagar, Bareilly, UP 243122 India
| | - R. R. Kumar
- Division of Livestock Products Technology, ICAR-Indian Veterinary Research Institute, Izatnagar, Bareilly, UP 243122 India
| | - R. K. Agrawal
- Division of Livestock Products Technology, ICAR-Indian Veterinary Research Institute, Izatnagar, Bareilly, UP 243122 India
| | - A. Soni
- Division of Livestock Products Technology, ICAR-Indian Veterinary Research Institute, Izatnagar, Bareilly, UP 243122 India
| | - A. Luke
- Division of Livestock Products Technology, ICAR-Indian Veterinary Research Institute, Izatnagar, Bareilly, UP 243122 India
| | - S. Chand
- Division of Livestock Products Technology, ICAR-Indian Veterinary Research Institute, Izatnagar, Bareilly, UP 243122 India
| |
Collapse
|
23
|
|
24
|
Abstract
Femoral condyle fracture in coronal plane, also known as Hoffa fracture, is a rare fracture. Non-union of Hoffa fracture is even rarer. We present a case of fibrous nonunion of a Hoffa fracture in which the fractured fragment, though not freely movable, led to painful walking. Since the fragment was un-displaced and non-movable we fixed the fractured fragment in situ. Patient regained full range of motion of the knee and was asymptomatic on follow-up.
Collapse
Affiliation(s)
- A Soni
- Department of Orthopaedics, Government Medical College and Hospital, Chandigarh, India
| | - R Kansay
- Department of Orthopaedics, Government Medical College and Hospital, Chandigarh, India
| | - S Gupta
- Department of Orthopaedics, Government Medical College and Hospital, Chandigarh, India
| | - A Malhotra
- Department of Orthopaedics, Government Medical College and Hospital, Chandigarh, India
| |
Collapse
|
25
|
Stein JE, Soni A, Danilova L, Cottrell TR, Gajewski TF, Hodi FS, Bhatia S, Urba WJ, Sharfman WH, Wind-Rotolo M, Edwards R, Lipson EJ, Taube JM. Major pathologic response on biopsy (MPRbx) in patients with advanced melanoma treated with anti-PD-1: evidence for an early, on-therapy biomarker of response. Ann Oncol 2019; 30:589-596. [PMID: 30689736 PMCID: PMC6503625 DOI: 10.1093/annonc/mdz019] [Citation(s) in RCA: 37] [Impact Index Per Article: 7.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/31/2022] Open
Abstract
BACKGROUND With increasing anti-PD-1 therapy use in patients with melanoma and other tumor types, there is interest in developing early on-treatment biomarkers that correlate with long-term patient outcome. An understanding of the pathologic features of immune-mediated tumor regression is key in this endeavor. MATERIALS AND METHODS Histologic features of immune-related pathologic response (irPR) following anti-PD-1 therapy were identified on hematoxylin and eosin (H&E)-stained slides in a discovery cohort of pre- and on-treatment specimens from n = 16 patients with advanced melanoma. These features were used to generate an irPR score [from 0 = no irPR features to 3 = major pathologic response on biopsy (MPRbx, ≤10% residual viable tumor)]. This scoring system was then tested for an association with objective response by RECIST1.1 and overall survival in a prospectively collected validation cohort of pre- and on-treatment biopsies (n = 51 on-treatment at 4-week timepoint) from melanoma patients enrolled on the nivolumab monotherapy arm of CA209-038 (NCT01621490). RESULTS Specimens from responders in the discovery cohort had features of immune-activation (moderate-high TIL densities, plasma cells) and wound-healing/tissue repair (neovascularization, proliferative fibrosis) compared to nonresponders, (P ≤ 0.021, for each feature). In the validation cohort, increasing irPR score associated with objective response (P = 0.009) and MPRbx associated with increased overall survival (n = 51; HR 0.13; 95%CI, 0.054-0.31, P = 0.015). Neither tumoral necrosis nor pretreatment histologic features were associated with response. Eight of 16 (50%) of patients with stable disease showed irPR features, two of which were MPRbx, indicating a disconnect between pathologic and radiographic features at the 4-week on-therapy timepoint for some patients. CONCLUSIONS Features of immune-mediated tumor regression on routine H&E-stained biopsy slides from patients with advanced melanoma correlate with objective response to anti-PD-1 and overall survival. An on-therapy biopsy may be particularly clinically useful for informing treatment decisions in patients with radiographic stable disease. This approach is inexpensive, straightforward, and widely available.
Collapse
Affiliation(s)
| | - A Soni
- Departments of Dermatology
| | - L Danilova
- Biostatistics, Johns Hopkins University SOM, Baltimore; The Bloomberg-Kimmel Institute for Cancer Immunotherapy, Johns Hopkins, Baltimore
| | - T R Cottrell
- Department of Pathology, Johns Hopkins University SOM, Baltimore
| | - T F Gajewski
- Section of Hematology/Oncology, Department of Medicine, University of Chicago, Chicago
| | - F S Hodi
- Department of Medical Oncology, Dana-Farber Cancer Institute, Boston
| | - S Bhatia
- Fred Hutchinson Cancer Research Center, University of Washington, Seattle
| | - W J Urba
- Earle A. Chiles Research Institute, Providence Cancer Center, Portland
| | - W H Sharfman
- The Bloomberg-Kimmel Institute for Cancer Immunotherapy, Johns Hopkins, Baltimore; Department of Oncology, The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University SOM, Baltimore
| | | | - R Edwards
- Bristol-Myers Squibb, Princeton, USA
| | - E J Lipson
- The Bloomberg-Kimmel Institute for Cancer Immunotherapy, Johns Hopkins, Baltimore; Department of Oncology, The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University SOM, Baltimore
| | - J M Taube
- Departments of Dermatology; The Bloomberg-Kimmel Institute for Cancer Immunotherapy, Johns Hopkins, Baltimore; Department of Pathology, Johns Hopkins University SOM, Baltimore; Department of Oncology, The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University SOM, Baltimore.
| |
Collapse
|
26
|
Swami D, Yadav R, Bhaskar ASB, Soni A, Nagar DP, Acharya J, Karade HN, Singh KP, Kumar P. Comparative evaluation of antidotal efficacy of 2-PAM and HNK-102 oximes during inhalation of sarin vapor in Swiss albino mice. Inhal Toxicol 2018; 30:287-298. [PMID: 30375901 DOI: 10.1080/08958378.2018.1520369] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/04/2023]
Abstract
Efficacy of two oximes treatments evaluated during inhalation of sarin vapor (LCt50, 755.9 mg/min/m3) in simulated real scenario in vivo. Majority of mice either became moribund or died within 1-2 min during exposure to multifold-lethal concentrations of sarin vapor. Protection indices were determined by exposing to sarin vapor in two sessions, 1 min exposure followed by treatments with or without HNK-102 (56.56 mg/kg, im) or 2-PAM (30 mg/kg, im) and atropine (10 mg/kg, ip), and again exposed for remaining 14 min. Protection offered by HNK-102 was found to be four folds higher compared to 2-PAM in the same toxic environment. Secondly, sub-lethal concentration of sarin vapor (0.8 × LCt50 or 605 mg/min/m3), 24 h post investigations revealed that the oximes could not reactivate brain and serum acetylcholinesterase (AChE) activity. The treatments prevented increase in protein concentration (p < .05) and macrophages infiltration compared to sarin alone group in broncho-alveolar lavage fluid. Lung histopathology showed intense peribronchial infiltration and edema with desquamating epithelial lining and mild to moderate alveolar septal infiltration in sarin and atropine groups, respectively. Noticeable peeling-off observed in epithelial lining and sporadic mild infiltration of epithelial cells at bronchiolar region in 2-PAM and HNK-102 groups, respectively. The oximes failed to reactivate AChE activity; however, the mice survived up to 6.0 × LCt50, proved involvement of non-AChE targets in sarin toxicity. Atropine alone treatment was found to be either ineffective or increased the toxicity. HNK-102, exhibited better survivability with lung protection, can be considered as a better replacement for 2-PAM to treat sarin inhalation induced poisoning.
Collapse
Affiliation(s)
- Devyani Swami
- a Pharmacology and Toxicology Division , Defence Research & Development Establishment , Gwalior , India
| | - Ruchi Yadav
- a Pharmacology and Toxicology Division , Defence Research & Development Establishment , Gwalior , India
| | - A S B Bhaskar
- a Pharmacology and Toxicology Division , Defence Research & Development Establishment , Gwalior , India
| | - A Soni
- a Pharmacology and Toxicology Division , Defence Research & Development Establishment , Gwalior , India
| | - D P Nagar
- a Pharmacology and Toxicology Division , Defence Research & Development Establishment , Gwalior , India
| | - J Acharya
- b Process Technology Development Division , Defence Research & Development Establishment , Gwalior , India
| | - H N Karade
- b Process Technology Development Division , Defence Research & Development Establishment , Gwalior , India
| | - K P Singh
- a Pharmacology and Toxicology Division , Defence Research & Development Establishment , Gwalior , India
| | - Pravin Kumar
- a Pharmacology and Toxicology Division , Defence Research & Development Establishment , Gwalior , India
| |
Collapse
|
27
|
Mathur SC, Shekhawat NS, Nama SL, Khichi CP, Soni A, Mathur S, Parihar VS. The Wood-Boring Trace Fossil <i>Asthenopodichnium</i> from Palaeocene Sediments of the Barmer Hill Formation, Western Rajasthan, India. CURR SCI INDIA 2018. [DOI: 10.18520/cs/v114/i07/1544-1548] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
|
28
|
Abstract
Dentistry and pharmacy have an opportunity, through interprofessional working, to spearhead a move towards more integrated healthcare provision, in particular for patients with chronic non-communicable diseases such as diabetes. The proposed interprofessional working poses certain challenges, but offers may opportunities and benefits.
Collapse
Affiliation(s)
| | - A Soni
- Royal Pharmaceutical Society, Royal Pharmaceutical Society
| |
Collapse
|
29
|
Lowres N, Chao T, Chen S, Chen Y, Diederichsen A, Fitzmaurice D, Gomez-Doblas J, Harbison J, Hobbs F, Kaasenbrood F, Lee V, Lindholt J, Lip G, Mairesse G, McManus D, Muñiz García J, Orchard J, Pérula De Torres L, Proietti M, Rioboó E, Roalfe A, Schnabel R, Smyth B, Soni A, Tieleman R, Wang J, Wild P, Yan B, Freedman B. High Stroke Risk of Patients Aged ≥65 Years with Screen-Detected Atrial Fibrillation: Collaboration and Meta-Analysis of 15 Screening Studies. Heart Lung Circ 2018. [DOI: 10.1016/j.hlc.2018.06.026] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|
30
|
Kempton CL, Recht M, Neff A, Wang M, Buckner TW, Soni A, Quon D, Witkop M, Boggio L, Gut RZ, Cooper DL. Impact of pain and functional impairment in US adults with haemophilia: Patient-reported outcomes and musculoskeletal evaluation in the pain, functional impairment and quality of life (P-FiQ) study. Haemophilia 2017; 24:261-270. [DOI: 10.1111/hae.13377] [Citation(s) in RCA: 32] [Impact Index Per Article: 4.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 10/30/2017] [Indexed: 01/19/2023]
Affiliation(s)
| | - M. Recht
- Oregon Health & Science University; Portland OR USA
| | - A. Neff
- Cleveland Clinic; Cleveland OH USA
| | - M. Wang
- University of Colorado School of Medicine; Aurora CO USA
| | - T. W. Buckner
- University of Colorado School of Medicine; Aurora CO USA
| | - A. Soni
- Center for Inherited Blood Disorders; CHOC Children's Hospital/UC Irvine; Orange CA USA
| | - D. Quon
- Orthopaedic Hemophilia Treatment Center; Orthopaedic Institute for Children; Los Angeles CA USA
| | - M. Witkop
- Munson Medical Center; Traverse City MI USA
| | - L. Boggio
- Rush University Medical Center; Chicago IL USA
| | - R. Z. Gut
- Novo Nordisk Inc.; Plainsboro NJ USA
| | | |
Collapse
|
31
|
Affiliation(s)
- D J Thomson
- Department of General Medicine, John Radcliffe Hospital, Oxford, UK
| | | | | | | |
Collapse
|
32
|
McGuinn C, Cheng D, Aschman D, Carpenter SL, Sidonio R, Soni A, Tarantino MD, Wheeler AP, Dunn AL. Radionuclide synovectomy/synoviorthesis (RS) in patients with bleeding disorders: A review of patient and procedure demographics and functional outcomes in the ATHNdataset. Haemophilia 2017; 23:926-933. [DOI: 10.1111/hae.13318] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 07/10/2017] [Indexed: 11/28/2022]
Affiliation(s)
- C. McGuinn
- Weill Cornell Medical College; New York NY USA
| | - D. Cheng
- American Thrombosis and Hemostasis Network; Riverwoods IL USA
| | - D. Aschman
- American Thrombosis and Hemostasis Network; Riverwoods IL USA
| | | | - R. Sidonio
- Emory University/Children's Healthcare of Atlanta Comprehensive Bleeding Disorder Clinic; Atlanta GA USA
| | - A. Soni
- Center for Comprehensive Care and Diagnosis of Inherited Blood Disorders; Orange CA USA
| | - M. D. Tarantino
- Bleeding and Clotting Disorders Institute; University of Illinois College of Medicine-Peoria; Peoria IL USA
| | - A. P. Wheeler
- Vanderbilt University Medical Center; Nashville TN USA
| | - A. L. Dunn
- Nationwide Children's Hospital/Ohio State University; Columbus OH USA
| | | |
Collapse
|
33
|
Sharma R, Dunn A, Aschman D, Cheng D, Wheeler A, Soni A, McGuinn C, Knoll C, Stein DT, Young G, French J, Sanders J, Davis JA, Tarantino M, Lim M, Gruppo R, Sidonio R, Ahuja S, Carpenter S, Pipe S, Shapiro A. Radionuclide synovectomy/synoviorthesis (RS) in persons with bleeding disorders: A review of impact of national guidance on frequency of RS using the ATHNdataset. Haemophilia 2017; 23:e385-e388. [DOI: 10.1111/hae.13273] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 04/19/2017] [Indexed: 11/29/2022]
Affiliation(s)
- R. Sharma
- BloodCenter of Wisconsin; Milwaukee WI USA
| | - A. Dunn
- Nationwide Children's Hospital; Columbus OH USA
| | - D. Aschman
- American Thrombosis and Hemostasis Network; Riverwoods IL USA
| | - D. Cheng
- American Thrombosis and Hemostasis Network; Riverwoods IL USA
| | - A. Wheeler
- Vanderbilt University Medical Center; Nashville TN USA
| | - A. Soni
- Center for Comprehensive Care and Diagnosis of Inherited Blood Disorders; Orange CA USA
| | | | - C. Knoll
- Arizona Hemophilia and Thrombosis Center; University of Arizona Health Sciences Center; Tucson AZ USA
| | - D. T. Stein
- Northwest Ohio Hemophilia Treatment Center; Toledo OH USA
| | - G. Young
- Childrens Hospital Los Angeles; Los Angeles CA USA
| | - J. French
- Palmetto Health Richland; Columbia SC USA
| | - J. Sanders
- Cook Children's Hospital; Fort Worth Bleeding Disorders Program; Fort Worth TX USA
| | - J. A. Davis
- University of Miami Comprehensive Pediatric Hemophilia Treatment Center; Miami FL USA
| | - M. Tarantino
- Bleeding and Clotting Disorders Institute; University of Illinois College of Medicine-Peoria; Peoria IL USA
| | - M. Lim
- UNC Comprehensive Hemophilia Diagnostic and Treatment Center; Chapel Hill NC USA
| | - R. Gruppo
- Cincinnati Children's Hospital Medical Center; Cincinnati OH USA
| | - R. Sidonio
- Emory/Children's Healthcare of Atlanta Comprehensive Hemophilia Program; Atlanta GA USA
| | - S. Ahuja
- Rainbow Babies & Children's Hospital; University Hospitals Case Medical Center; Cleveland OH USA
| | | | - S. Pipe
- Department of Pediatrics and Pathology; University of Michigan; Ann Arbor MI USA
| | - A. Shapiro
- Indiana Hemophilia and Thrombosis Center; Indianapolis IN USA
| |
Collapse
|
34
|
Warner SC, Walsh DA, Laslett LL, Maciewicz RA, Soni A, Hart DJ, Zhang W, Muir KR, Dennison EM, Leaverton P, Rampersaud E, Cooper C, Spector TD, Cicuttini FM, Arden NK, Jones G, Doherty M, Valdes AM. Pain in knee osteoarthritis is associated with variation in the neurokinin 1/substance P receptor (TACR1) gene. Eur J Pain 2017; 21:1277-1284. [PMID: 28493529 DOI: 10.1002/ejp.1027] [Citation(s) in RCA: 19] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 01/21/2017] [Indexed: 01/02/2023]
Abstract
BACKGROUND Substance P (SP) is a pain- and inflammation-related neuropeptide which preferentially binds to the neurokinin receptor 1 (NK1 ). SP and NK1 receptors have been implicated in joint pain, inflammation and damage in animal models and human studies of osteoarthritis (OA). The aim of this study was to test if genetic variation at the neurokinin 1 receptor gene (TACR1) is associated with pain in individuals with radiographic knee OA. METHODS Participants from the Genetics of OA and Lifestyle study were used for the discovery group (n = 1615). Genotype data for six SNPs selected to cover most variation in the TACR1 gene were used to test for an association with symptomatic OA. Replication analysis was performed using data from the Chingford 1000 Women Study, Hertfordshire Cohort Study, Tasmanian Older Adult Cohort Study and the Clearwater OA Study. In total, n = 1715 symptomatic OA and n = 735 asymptomatic OA individuals were analysed. RESULTS Out of six SNPs tested in the TACR1 gene, one (rs11688000) showed a nominally significant association with a decreased risk of symptomatic OA in the discovery cohort. This was then replicated in four additional cohorts. After adjusting for age, gender, body mass index and radiographic severity, the G (minor) allele at rs11688000 was associated with a decreased risk of symptomatic OA compared to asymptomatic OA cases (p = 9.90 × 10-4 , OR = 0.79 95% 0.68-0.90 after meta-analysis). CONCLUSIONS This study supports a contribution from the TACR1 gene in human OA pain, supporting further investigation of this gene's function in OA. SIGNIFICANCE This study contributes to the knowledge of the genetics of painful osteoarthritis, a condition which affects millions of individuals worldwide. Specifically, a contribution from the TACR1 gene to modulating pain sensitivity in osteoarthritis is suggested.
Collapse
Affiliation(s)
- S C Warner
- Academic Rheumatology, University of Nottingham, UK.,Department of Cardiovascular Sciences, Leicester Cardiovascular Biomedical Research Unit, University of Leicester and National Institute for Health Research, UK
| | - D A Walsh
- Academic Rheumatology, University of Nottingham, UK.,Arthritis Research UK Pain Centre, School of Medicine, University of Nottingham, UK
| | - L L Laslett
- Menzies Institute for Medical Research, University of Tasmania, Hobart, Australia
| | - R A Maciewicz
- Respiratory, Inflammation and Autoimmunity Innovative Medicines, AstraZeneca, Cambridge, UK
| | - A Soni
- NIHR Musculoskeletal Biomedical Research Unit, University of Oxford, UK
| | - D J Hart
- Department of Twin Research, St Thomas' Hospital, King's College London, UK
| | - W Zhang
- Academic Rheumatology, University of Nottingham, UK.,Arthritis Research UK Pain Centre, School of Medicine, University of Nottingham, UK
| | - K R Muir
- Institute of Population Health, University of Manchester, UK
| | - E M Dennison
- MRC Lifecourse Epidemiology Unit, Southampton General Hospital, University of Southampton, UK
| | - P Leaverton
- The Arthritis Research Institute of America, Clearwater, USA
| | - E Rampersaud
- University of Miami Miller School of Medicine, USA
| | - C Cooper
- NIHR Musculoskeletal Biomedical Research Unit, University of Oxford, UK.,MRC Lifecourse Epidemiology Unit, Southampton General Hospital, University of Southampton, UK
| | - T D Spector
- Department of Twin Research, St Thomas' Hospital, King's College London, UK
| | - F M Cicuttini
- Department of Epidemiology and Preventive Medicine, Monash University Medical School, Melbourne, Australia
| | - N K Arden
- NIHR Musculoskeletal Biomedical Research Unit, University of Oxford, UK.,MRC Lifecourse Epidemiology Unit, Southampton General Hospital, University of Southampton, UK
| | - G Jones
- Menzies Institute for Medical Research, University of Tasmania, Hobart, Australia
| | - M Doherty
- Academic Rheumatology, University of Nottingham, UK.,Arthritis Research UK Pain Centre, School of Medicine, University of Nottingham, UK
| | - A M Valdes
- Academic Rheumatology, University of Nottingham, UK.,Arthritis Research UK Pain Centre, School of Medicine, University of Nottingham, UK
| |
Collapse
|
35
|
Soni A, Singh P, Shah R, Bagotia S. Impact of Cognition and Clinical Factors on Functional Outcome in Patients with Bipolar Disorder. East Asian Arch Psychiatry 2017; 27:26-34. [PMID: 28387210] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/07/2023]
Abstract
OBJECTIVE To examine the role of different clinical variables and cognition on functional outcome in patients with bipolar disorder. METHODS A total of 61 euthymic patients with bipolar disorder and 30 healthy individuals were included in the study. The patients were divided into low functioning (n = 30) or high functioning (n = 31) subgroups based on functioning level measured by Global Assessment of Functioning Scale score. Groups were subjected to neurocognitive and clinical assessment. RESULTS Clinical variables differed significantly between low and high functioning patient groups, namely total number of episodes, depressive episodes, and time since the last episode. These variables were also correlated significantly with Global Assessment of Functioning Scale score. All 3 groups differed significantly for digit span backward test, verbal learning and memory test, Trail Making Test, and Stroop Colour Test. Digit span backward test, Trail Making Test, and Stroop Colour Test were significantly correlated with Global Assessment of Functioning Scale score. CONCLUSIONS Total episodes, depressive episodes, time since the last episode, and cognitive dysfunction correlated with poor functioning. Executive dysfunction was the strongest predictor of psychosocial outcome in euthymic bipolar patients. Long-term therapeutic interventions should target relapse prevention with special consideration given to depressive episodes and cognitive rehabilitation.
Collapse
Affiliation(s)
- A Soni
- Department of Psychiatry SMS Medical College Jaipur, Rajasthan, India
| | - P Singh
- Department of Psychiatry SMS Medical College Jaipur, Rajasthan, India
| | - R Shah
- Department of Psychiatry SMS Medical College Jaipur, Rajasthan, India
| | - S Bagotia
- Department of Psychiatry SMS Medical College Jaipur, Rajasthan, India
| |
Collapse
|
36
|
Fahey N, Soni A, Allison J, Vankar J, Prabhakaran A, Simas TM, Byatt N, Phatak A, O'Keefe E, Nimbalkar S. Higher levels of education mitigate the relationship between perceived
stress and common mental disorders among women in rural India: results of a
cross-sectional study. Ann Glob Health 2016. [DOI: 10.1016/j.aogh.2016.04.505] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022] Open
|
37
|
Nimbalkar S, Talati K, Phatak A, Fahey N, Soni A, Patel D, Talati K, Bansal S, Allison J. Delayed initiation and non-exclusive breastfeeding needs attention in
Tribal Gujarat, India. Ann Glob Health 2016. [DOI: 10.1016/j.aogh.2016.04.647] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022] Open
|
38
|
Abstract
Background and Rationale: Medical professionals’ attitude towards homosexuals affects health care offered to such patients with a different sexual orientation. There is absence of literature that explores the attitudes of Indian medical students or physicians towards homosexuality. Aim: This study aimed to evaluate Indian medical students and interns’ knowledge about homosexuality and attitude towards homosexuals. Materials and Methods: After IEC approval and written informed consent, a cross-sectional study was conducted on a purposive sample of undergraduate medical students and interns studying in one Indian medical college. The response rate was 80.5%. Only completely and validly filled responses (N = 244) were analyzed. The participants filled the Sex Education and Knowledge about Homosexuality Questionnaire (SEKHQ) and the Attitudes towards Homosexuals Questionnaire (AHQ). SEKHQ consisted of 32 statements with response chosen from ‘true’, ‘false’, or ‘don’t know’. AHQ consisted of 20 statements scorable on a 5-point Likert scale. Multiple linear regression was used to find the predictors of knowledge and attitude. Results: Medical students and interns had inadequate knowledge about homosexuality, although they endorsed a neutral stance insofar as their attitude towards homosexuals is concerned. Females had more positive attitudes towards homosexuals. Knowledge emerged as the most significant predictor of attitude; those having higher knowledge had more positive attitudes. Conclusion: Enhancing knowledge of medical students by incorporation of homosexuality related health issues in the curriculum could help reduce prejudice towards the sexual minority and thus impact their future clinical practice.
Collapse
Affiliation(s)
- G Banwari
- Department of Psychiatry, Smt. NHL Municipal Medical College and Sheth VS General Hospital, Ahmedabad, Gujarat, India
| | | | | | | | | |
Collapse
|
39
|
Palan CB, Koparkar KA, Bajaj NS, Soni A, Omanwar SK. A novel high sensitivity KCaPO4:Ce3+ phosphor for radiation dosimetry. Res Chem Intermed 2016. [DOI: 10.1007/s11164-016-2558-z] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
40
|
Mishra DR, Soni A, Rawat NS, Bokam G. Study of thermoluminescence (TL) and optically stimulated luminescence (OSL) from α-keratin protein found in human hairs and nails: potential use in radiation dosimetry. Radiat Environ Biophys 2016; 55:255-264. [PMID: 26846648 DOI: 10.1007/s00411-016-0634-9] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 06/30/2014] [Accepted: 01/16/2016] [Indexed: 06/05/2023]
Abstract
The thermoluminescence (TL) and optically stimulated luminescence (OSL) properties of human nails and hairs containing α-keratin proteins have been investigated. For the present studies, black hairs and finger nails were selectively collected from individuals with ages between 25 and 35 years. The collected hairs/nails were cut to a size of < 1 mm and cleaned with distilled water to remove dirt and other potential physical sources of contamination. All samples were optically beached with 470 nm of LED light at 60 mW/cm(2) intensity and irradiated by a (60)Co γ source. The hair and nail samples showed overlapping multiple TL glow peaks in the temperature range from 70 to 210 ° C. Continuous wave (CW)-OSL measurements of hair samples at a wavelength of 470 nm showed the presence of two distinct OSL components with photoionization cross section (PIC) values of about 1.65 × 10(-18) cm(2) and about 3.48 × 10(-19) cm(2), while measurements of nail samples showed PIC values of about 6.98 × 10(-18) cm(2) and about 8.7 × 10(-19) cm(2), respectively. This difference in PIC values for hair and nail samples from the same individual is attributed to different arrangement of α-keratin protein concentrations in the samples. The OSL sensitivity was found to vary ± 5 times among nail and hair samples from different individuals, with significant fading (60% in 11 h) at room temperature. The remaining signal (after fading) can be useful for dose estimation when a highly sensitive OSL reader is used. In the absorbed dose range of 100 mGy-100 Gy, both the TL and OSL signals of hair and nail samples showed linear dose dependence. The results obtained in the present study suggest that OSL using hair and nail samples may provide a supplementary method of dose estimation in radiological and nuclear emergencies.
Collapse
Affiliation(s)
- D R Mishra
- Radiological Physics and Advisory Division, Bhabha Atomic Research Centre, Mumbai, 400 085, India.
| | - A Soni
- Radiological Physics and Advisory Division, Bhabha Atomic Research Centre, Mumbai, 400 085, India
| | - N S Rawat
- Radiological Physics and Advisory Division, Bhabha Atomic Research Centre, Mumbai, 400 085, India
| | - G Bokam
- Radiological Safety Division, Atomic Energy Regulatory Board, Mumbai, 400 094, India
| |
Collapse
|
41
|
Burman T, Bhateja P, Dube S, Soni A. In vitro and in vivo activity of “compound A” against gram-positive and -negative pathogens including MDR strains. Int J Infect Dis 2016. [DOI: 10.1016/j.ijid.2016.02.317] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022] Open
|
42
|
Soni A, Arivarasan K, Sachdeva S, Kumar A, Sakhuja P, Puri AS. Education and Imaging. Hepatobiliary and Pancreatic: Spontaneous bilioma secondary to ampullary cancer: a rare presentation. J Gastroenterol Hepatol 2016. [PMID: 26202225 DOI: 10.1111/jgh.13054] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/18/2022]
Affiliation(s)
- A Soni
- Department of Gastroenterology, GB Pant Hospital, New Delhi, India, 110002
| | - K Arivarasan
- Department of Gastroenterology, GB Pant Hospital, New Delhi, India, 110002
| | - S Sachdeva
- Department of Gastroenterology, GB Pant Hospital, New Delhi, India, 110002
| | - A Kumar
- Department of Gastroenterology, GB Pant Hospital, New Delhi, India, 110002
| | - P Sakhuja
- Department of Pathology, GB Pant Hospital, New Delhi, India, 110002
| | - A S Puri
- Department of Gastroenterology, GB Pant Hospital, New Delhi, India, 110002
| |
Collapse
|
43
|
Bai Z, Blum T, Boyle PA, Christ NH, Frison J, Garron N, Izubuchi T, Jung C, Kelly C, Lehner C, Mawhinney RD, Sachrajda CT, Soni A, Zhang D. Standard Model Prediction for Direct CP Violation in K→ππ Decay. Phys Rev Lett 2015; 115:212001. [PMID: 26636846 DOI: 10.1103/physrevlett.115.212001] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 06/04/2015] [Indexed: 06/05/2023]
Abstract
We report the first lattice QCD calculation of the complex kaon decay amplitude A_{0} with physical kinematics, using a 32³×64 lattice volume and a single lattice spacing a, with 1/a=1.3784(68) GeV. We find Re(A_{0})=4.66(1.00)(1.26)×10(-7) GeV and Im(A_{0})=-1.90(1.23)(1.08)×10(-11) GeV, where the first error is statistical and the second systematic. The first value is in approximate agreement with the experimental result: Re(A_{0})=3.3201(18)×10(-7) GeV, while the second can be used to compute the direct CP-violating ratio Re(ϵ^{'}/ϵ)=1.38(5.15)(4.59)×10^{-4}, which is 2.1σ below the experimental value 16.6(2.3)×10(-4). The real part of A_{0} is CP conserving and serves as a test of our method while the result for Re(ϵ^{'}/ϵ) provides a new test of the standard model theory of CP violation, one which can be made more accurate with increasing computer capability.
Collapse
Affiliation(s)
- Z Bai
- Physics Department, Columbia University, New York, New York 10027, USA
| | - T Blum
- Physics Department, University of Connecticut, Storrs, Connecticut 06269-3046, USA
| | - P A Boyle
- SUPA, School of Physics, The University of Edinburgh, Edinburgh EH9 3JZ, United Kingdom
| | - N H Christ
- Physics Department, Columbia University, New York, New York 10027, USA
| | - J Frison
- SUPA, School of Physics, The University of Edinburgh, Edinburgh EH9 3JZ, United Kingdom
| | - N Garron
- School of Computing & Mathematics, Plymouth University, Plymouth PL4 8AA, United Kingdom
| | - T Izubuchi
- Physics Department, Brookhaven National Laboratory, Upton, New York 11973, USA
- RIKEN-BNL Research Center, Brookhaven National Laboratory, Upton, New York 11973, USA
| | - C Jung
- Physics Department, Brookhaven National Laboratory, Upton, New York 11973, USA
| | - C Kelly
- RIKEN-BNL Research Center, Brookhaven National Laboratory, Upton, New York 11973, USA
| | - C Lehner
- Physics Department, Brookhaven National Laboratory, Upton, New York 11973, USA
| | - R D Mawhinney
- Physics Department, Columbia University, New York, New York 10027, USA
| | - C T Sachrajda
- School of Physics and Astronomy, University of Southampton, Southampton SO17 1BJ, United Kingdom
| | - A Soni
- Physics Department, Brookhaven National Laboratory, Upton, New York 11973, USA
| | - D Zhang
- Physics Department, Columbia University, New York, New York 10027, USA
| |
Collapse
|
44
|
Tripathi R, Soni A, Tyagi A, Mehta S, Gupta S. Comparative Study of Neurological Soft Signs in Patients with Schizophrenia or Obsessive-compulsive Disorder, and Healthy Controls. East Asian Arch Psychiatry 2015; 25:64-72. [PMID: 26118745] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/04/2023]
Abstract
OBJECTIVE The primary objective of this study was to examine neurological soft signs in patients with obsessive-compulsive disorder compared with patients with schizophrenia and a control group in the Indian setting. The secondary objective was to find any correlation between age at onset and neurological soft signs scores, as well as that between severity of obsessive-compulsive disorder symptoms (total Yale-Brown Obsessive Compulsive Scale score) and neurological soft signs scores. METHODS This was a cross-sectional hospital-based study of 135 individuals (45 patients with schizophrenia, 45 patients with obsessive-compulsive disorder who were attending the psychiatric outpatient department of Sawai Man Singh Medical College, Jaipur, India, and 45 matched healthy controls) from 20 June 2013 to 22 December 2014. After applying strict inclusion and exclusion criteria, the participants completed the study instruments (Cambridge Neurological Inventory [Part 2] and Yale-Brown Obsessive Compulsive Scale). Their socio-demographic data were also recorded. RESULTS The neurological soft signs total score and domain scores (motor coordination, sensory integration, and disinhibition) were significantly higher in patients with schizophrenia (p < 0.05) than in the obsessive-compulsive disorder group or the control group. The obsessive-compulsive disorder group did not significantly differ from the control group in terms of neurological soft signs scores. No correlation was found between neurological soft signs scores and age at onset as well as that between neurological soft signs scores and total Yale-Brown Obsessive Compulsive Scale score. CONCLUSION Neurological soft signs assessed by the Cambridge Neurological Inventory and Yale-Brown Obsessive Compulsive Scale, which discriminate patients with schizophrenia from controls, appear to be relatively specific to schizophrenia. Further studies are required to explore neurological soft signs in patients with obsessive-compulsive disorder.
Collapse
Affiliation(s)
- R Tripathi
- Department of Psychiatry, Sawai Man Singh Medical College, Jaipur, India
| | - A Soni
- Department of Psychiatry, Sawai Man Singh Medical College, Jaipur, India
| | - A Tyagi
- Department of Psychiatry, Sawai Man Singh Medical College, Jaipur, India
| | - S Mehta
- Navjeevan Hospital, Hisar, Haryana, India
| | - S Gupta
- Department of Psychiatry, Sawai Man Singh Medical College, Jaipur, India
| |
Collapse
|
45
|
Soni A. SP0085 Functional MRI from Acute to Chronic Pain and Placebo Effects in Joint Diseases. Ann Rheum Dis 2015. [DOI: 10.1136/annrheumdis-2015-eular.6663] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|
46
|
Fogarty PF, Mancuso ME, Kasthuri R, Bidlingmaier C, Chitlur M, Gomez K, Holme PA, James P, Kruse-Jarres R, Mahlangu J, Mingot-Castellano ME, Soni A. Presentation and management of acute coronary syndromes among adult persons with haemophilia: results of an international, retrospective, 10-year survey. Haemophilia 2015; 21:589-97. [DOI: 10.1111/hae.12652] [Citation(s) in RCA: 31] [Impact Index Per Article: 3.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 01/07/2015] [Indexed: 01/01/2023]
Affiliation(s)
- P. F. Fogarty
- Penn Comprehensive Hemophilia and Thrombosis Program; Philadelphia PA USA
| | - M. E. Mancuso
- Angelo Bianchi Bonomi Hemophilia and Thrombosis Center; Fondazione IRCCS Ca’ Granda, Ospedale Maggiore Policlinico; Milan Italy
| | - R. Kasthuri
- Division of Hematology and Oncology; Hemophilia and Thrombosis Center; University of North Carolina; Chapel Hill NC USA
| | | | - M. Chitlur
- Children's Hospital of Michigan; Detroit MI USA
| | | | - P. A. Holme
- Department of Haematology; Oslo University Hospital, Rikshospitalet; Oslo Norway
| | - P. James
- Queen's University; Kingston ON Canada
| | | | - J. Mahlangu
- Faculty of Health Sciences; University of the Witwatersrand and Charlotte Maxeke Johannesburg Academic Hospital; Johannesburg South Africa
| | | | - A. Soni
- Children's Hospital of Orange County; Orange CA USA
| | | |
Collapse
|
47
|
Rawat N, Dhabekar B, Kulkarni M, Muthe K, Mishra D, Soni A, Gupta S, Babu D. Optimization of CW-OSL parameters for improved dose detection threshold in Al2O3:C. RADIAT MEAS 2014. [DOI: 10.1016/j.radmeas.2014.02.013] [Citation(s) in RCA: 29] [Impact Index Per Article: 2.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
48
|
Kulkarni M, Luszik-Bhadra M, Muthe K, Behrens R, Rawat N, Soni A, Mishra D, Gadkari S, Gupta S, Sharma D. New OSL detector combination for albedo neutron dosimetry. RADIAT MEAS 2014. [DOI: 10.1016/j.radmeas.2014.05.024] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
49
|
Bai Z, Christ NH, Izubuchi T, Sachrajda CT, Soni A, Yu J. K(L) - K(S) mass difference from lattice QCD. Phys Rev Lett 2014; 113:112003. [PMID: 25259970 DOI: 10.1103/physrevlett.113.112003] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 06/03/2014] [Indexed: 06/03/2023]
Abstract
We report on the first complete calculation of the K_{L}-K_{S} mass difference, ΔM_{K}, using lattice QCD. The calculation is performed on a 2+1 flavor, domain wall fermion ensemble with a 330 MeV pion mass and a 575 MeV kaon mass. We use a quenched charm quark with a 949 MeV mass to implement Glashow-Iliopoulos-Maiani cancellation. For these heavier-than-physical particle masses, we obtain ΔM_{K}=3.19(41)(96)×10^{-12} MeV, quite similar to the experimental value. Here the first error is statistical, and the second is an estimate of the systematic discretization error. An interesting aspect of this calculation is the importance of the disconnected diagrams, a dramatic failure of the Okubo-Zweig-Iizuka rule.
Collapse
Affiliation(s)
- Z Bai
- Physics Department, Columbia University, New York, New York 10027, USA
| | - N H Christ
- Physics Department, Columbia University, New York, New York 10027, USA
| | - T Izubuchi
- Brookhaven National Laboratory, Upton, New York 11973, USA and RIKEN-BNL Research Center, Brookhaven National Laboratory, Upton, New York 11973, USA
| | - C T Sachrajda
- School of Physics and Astronomy, University of Southampton, Southampton SO17 1BJ, United Kingdom
| | - A Soni
- Brookhaven National Laboratory, Upton, New York 11973, USA
| | - J Yu
- Physics Department, Columbia University, New York, New York 10027, USA
| |
Collapse
|
50
|
Sharma A, Astekar M, Metgud R, Soni A, Verma M, Patel S. A study of C-reactive protein, lipid metabolism and peripheral blood to identify a link between periodontitis and cardiovascular disease. Biotech Histochem 2014; 89:577-82. [PMID: 24974939 DOI: 10.3109/10520295.2014.918280] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Periodontitis is characterized by systemic inflammatory host responses that may contribute to a higher risk for cardiovascular disease. We hypothesized that periodontitis may be associated with altered C-reactive protein levels, serum levels of lipids and peripheral blood counts, and that these characteristics may serve as markers for a link between periodontitis and cardiovascular disease. Sixty subjects, 25-60 years old, were divided into three groups of 20 subjects each. Group 1, age and sex matched healthy controls; group 2, patients diagnosed with chronic periodontitis; group 3, patients diagnosed with acute periodontal lesions including periodontal abscess and pericoronal abscesses. Serum C-reactive protein levels, lipid levels and peripheral blood counts were obtained for all three groups. Significant increases in C-reactive protein and serum lipid levels, and altered peripheral blood counts were observed between the experimental groups; these factors were correlated with chronic periodontitis and cardiovascular disease. These simple, economical clinical measurements can be used to assess periodontal tissue damage and may be useful for predicting risk of cardiovascular disease in these subjects.
Collapse
Affiliation(s)
- A Sharma
- Department of Oral and Maxillofacial Pathology, Bhabha College of Dental Sciences , Hoshangabad Road, Bhopal, Madhya Pradesh , India
| | | | | | | | | | | |
Collapse
|